Prognostic relevance of programmed cell death-ligand 1 expression and CD8+ TILs in rectal cancer patients before and after neoadjuvant chemoradiotherapy.
Tsung-Wei ChenKevin Chih-Yang HuangShu-Fen ChiangWilliam Tzu-Liang ChenTao-Wei KeK S Clifford ChaoPublished in: Journal of cancer research and clinical oncology (2019)
The present results provide evidence that tumor PD-L1 expression and recruitment of CD8+ TILs within the tumor microenvironment were increased by neoCRT treatment. Tumor PD-L1 and CD8+ TILs are prognostic biomarkers for the survival of LARC patients treated with neoCRT.